PK and Food Effect of Pregabalin Study After Dosing in Healthy Male Volunteers
NCT02783638 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2019-01-16
Summary
This study is to assess the pharmacokinetics of Pregabalin controlled release formulation after multiple dosing as compared to Pregabalin immediate release formulation and the food effect of high fat diet after single dosing in healthy male volunteers.
Conditions
- Peripheral Neuropathy Pain
Interventions
- DRUG
-
YHD1119
2 by 2
- DRUG
-
Lyrica
2 by 2
Sponsors & Collaborators
-
Yuhan Corporation
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2016-04-30
- Completion
- 2016-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain
NCT02985216 ·Status: COMPLETED ·Phase: PHASE3
-
Pregabalin Peripheral Neuropathic Pain Study
NCT00141219 ·Status: COMPLETED ·Phase: PHASE3
-
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
NCT01057693 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.
NCT00219544 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Two Formulation of Pregabalin
NCT03712475 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS-NF1 Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects
NCT02326987 ·Status: COMPLETED ·Phase: PHASE1
-
An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers
NCT01257529 ·Status: COMPLETED ·Phase: PHASE1
-
PK Study of Pregabalin GLARS Tablet 150mg and IR Formulation After Multiple Dosing Under Fed Condition in Healthy Male Subjects
NCT01638273 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain
NCT05624853 ·Status: COMPLETED ·Phase: PHASE4
-
Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets
NCT04171453 ·Status: UNKNOWN
-
Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy
NCT01332149 ·Status: COMPLETED ·Phase: PHASE3
-
Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)
NCT01455428 ·Status: COMPLETED ·Phase: PHASE4
-
An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers
NCT01270815 ·Status: COMPLETED ·Phase: PHASE1
-
Pregabalin (Lyrica) for the Treatment of Essential Tremor
NCT00584376 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients
NCT00654940 ·Status: COMPLETED ·Phase: PHASE1
-
An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers
NCT01220219 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers
NCT01321671 ·Status: COMPLETED ·Phase: PHASE1
-
An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule
NCT01202422 ·Status: COMPLETED ·Phase: PHASE1
-
Lyrica (Pregabalin) Korean Post Marketing Surveillance Study
NCT01220180 ·Status: COMPLETED
-
Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy
NCT00553475 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)
NCT00156078 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects
NCT01635751 ·Status: COMPLETED ·Phase: PHASE1
-
Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan)
NCT01256593 ·Status: COMPLETED
-
The Clinical Effect of Pregabalin on Neuropathic Pain in Non Central Sensitized Patients After Total Knee Arthroplasty
NCT05322681 ·Status: UNKNOWN ·Phase: NA
-
An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers
NCT01257516 ·Status: COMPLETED ·Phase: PHASE1